These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9461179)

  • 1. Getting to the HAART of T cell dynamics.
    Roederer M
    Nat Med; 1998 Feb; 4(2):145-6. PubMed ID: 9461179
    [No Abstract]   [Full Text] [Related]  

  • 2. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation.
    Pakker NG; Notermans DW; de Boer RJ; Roos MT; de Wolf F; Hill A; Leonard JM; Danner SA; Miedema F; Schellekens PT
    Nat Med; 1998 Feb; 4(2):208-14. PubMed ID: 9461195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell changes after a short-term exposure to maraviroc in HIV-infected patients are related to antiviral activity.
    Pulido I; Machmach K; Romero-Sánchez MC; Genebat M; Mendez-Lagares G; Ruiz-Mateos E; Leal M
    J Infect; 2012 Apr; 64(4):417-23. PubMed ID: 22227467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China.
    Fang J; Bai S; Wu L; Zhu X; Yao X; Jin C; Wang C
    J Int Med Res; 2013 Oct; 41(5):1560-9. PubMed ID: 24043708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8 T-cell response to antiretroviral therapy.
    Stricker RB; Goldberg B
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):176-7. PubMed ID: 9241121
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV-1 and HAART: a time to cure, a time to kill.
    Saag MS; Kilby JM
    Nat Med; 1999 Jun; 5(6):609-11. PubMed ID: 10371490
    [No Abstract]   [Full Text] [Related]  

  • 7. CD20+ T cell numbers are decreased in untreated HIV-1 patients and recover after HAART.
    Förster F; Singla A; Arora SK; Schmidt RE; Jacobs R
    Immunol Lett; 2012 Aug; 146(1-2):74-8. PubMed ID: 22677201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant responses during antiretroviral therapy: role of immune activation and T cell redistribution rather than true CD4 T cell loss.
    Hazenberg MD; Otto SA; Wit FW; Lange JM; Hamann D; Miedema F
    AIDS; 2002 Jun; 16(9):1287-9. PubMed ID: 12045496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increases in T cell telomere length in HIV infection after antiretroviral combination therapy for HIV-1 infection implicate distinct population dynamics in CD4+ and CD8+ T cells.
    Kaushal S; Landay AL; Lederman MM; Connick E; Spritzler J; Kuritzkes DR; Kessler H; Levine BL; St Louis DC; June CH
    Clin Immunol; 1999 Jul; 92(1):14-24. PubMed ID: 10413649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis and the CD95 system in HIV disease: impact of highly active anti-retroviral therapy (HAART).
    Gougeon ML; Lecoeur H; Sasaki Y
    Immunol Lett; 1999 Mar; 66(1-3):97-103. PubMed ID: 10203040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly active anti-retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patients.
    Roger PM; Breittmayer JP; Arlotto C; Pugliese P; Pradier C; Bernard-Pomier G; Dellamonica P; Bernard A
    Clin Exp Immunol; 1999 Dec; 118(3):412-6. PubMed ID: 10594560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy.
    Fleury S; Rizzardi GP; Chapuis A; Tambussi G; Knabenhans C; Simeoni E; Meuwly JY; Corpataux JM; Lazzarin A; Miedema F; Pantaleo G
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5393-8. PubMed ID: 10805798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
    Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
    J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy.
    Giovannetti A; Ensoli F; Mazzetta F; De Cristofaro M; Pierdominici M; Muratori DS; Fiorelli V; Aiuti F
    Clin Exp Immunol; 1999 Oct; 118(1):87-94. PubMed ID: 10540164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensification of a suppressive HAART regimen increases CD4 counts and decreases CD8+ T-cell activation.
    Kolber MA; Saenz MO; Tanner TJ; Arheart KL; Pahwa S; Liu H
    Clin Immunol; 2008 Mar; 126(3):315-21. PubMed ID: 17997138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection.
    Kaufmann GR; Zaunders JJ; Cunningham P; Kelleher AD; Grey P; Smith D; Carr A; Cooper DA
    AIDS; 2000 Dec; 14(17):2643-51. PubMed ID: 11125882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functions of tetramer-stained HIV-specific CD4(+) and CD8(+) T cells.
    Kelleher AD; Rowland-Jones SL
    Curr Opin Immunol; 2000 Aug; 12(4):370-4. PubMed ID: 10899020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
    Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
    J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of viral load and immune complex load on CD4+ lymphocytes as a consequence of highly active antiretroviral treatment (HAART) in HIV-infected hemophilia patients.
    Daniel V; Süsal C; Melk A; Weimer R; Kröpelin M; Zimmermann R; Huth-Kühne A; Uhle C; Opelz G
    Immunol Lett; 1999 Aug; 69(2):283-9. PubMed ID: 10482364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM; Schapiro JM; Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.